Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For The Active Ingredient Interferon Beta-1A (Excl. For Intramuscular Injection), Atc L03Ab07 For The Period May 1St, 2023 - April 30Th, 2025